List StockArray ( [0] => RMD )This story features RESMED INC.For more info SHARE ANALYSIS: RMDThe company is included in ASX50, ASX100, ASX200, ASX300 and ALL-ORDSA brief look at important company events and economic data releases next week. For all economic data release dates, ex-div dates and times and other relevant information, please refer to the FNArena Calendar. Extreme US share price moves post earnings is the flavour du jour for the start of 2026, no doubt an indicator of what Australian investors can expect in the February reporting season. -The ASX200 has gained around 1% this week and is trading some -2% below its 52-week high. -A stronger AUD may be a key feature for companies with large USD-denominated earnings in the February reporting season, which starts next week with a trickle of companies.